356 related articles for article (PubMed ID: 25526932)
1. Discovery and development of DNA methyltransferase inhibitors using in silico approaches.
Medina-Franco JL; Méndez-Lucio O; Dueñas-González A; Yoo J
Drug Discov Today; 2015 May; 20(5):569-77. PubMed ID: 25526932
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of DNA methyltransferase-inhibitor interactions: Procyanidin B2 shows new promise for therapeutic intervention of cancer.
Shilpi A; Parbin S; Sengupta D; Kar S; Deb M; Rath SK; Pradhan N; Rakshit M; Patra SK
Chem Biol Interact; 2015 May; 233():122-38. PubMed ID: 25839702
[TBL] [Abstract][Full Text] [Related]
3. DNA methyltransferase inhibitors in cancer: a chemical and therapeutic patent overview and selected clinical studies.
Fahy J; Jeltsch A; Arimondo PB
Expert Opin Ther Pat; 2012 Dec; 22(12):1427-42. PubMed ID: 23033952
[TBL] [Abstract][Full Text] [Related]
4. Molecular Modeling and Chemoinformatics to Advance the Development of Modulators of Epigenetic Targets: A Focus on DNA Methyltransferases.
Prieto-Martínez FD; Peña-Castillo A; Méndez-Lucio O; Fernández-de Gortari E; Medina-Franco JL
Adv Protein Chem Struct Biol; 2016; 105():1-26. PubMed ID: 27567482
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic drug discovery: targeting DNA methyltransferases.
Foulks JM; Parnell KM; Nix RN; Chau S; Swierczek K; Saunders M; Wright K; Hendrickson TF; Ho KK; McCullar MV; Kanner SB
J Biomol Screen; 2012 Jan; 17(1):2-17. PubMed ID: 21965114
[TBL] [Abstract][Full Text] [Related]
6. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
Eglen RM; Reisine T
J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
[TBL] [Abstract][Full Text] [Related]
7. Advances in the computational development of DNA methyltransferase inhibitors.
Medina-Franco JL; Caulfield T
Drug Discov Today; 2011 May; 16(9-10):418-25. PubMed ID: 21315180
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
9. DNA methylation and its implications and accessibility for neuropsychiatric therapeutics.
Day JJ; Kennedy AJ; Sweatt JD
Annu Rev Pharmacol Toxicol; 2015; 55():591-611. PubMed ID: 25340930
[TBL] [Abstract][Full Text] [Related]
10. Targeting DNA methylation with small molecules: what's next?
Erdmann A; Halby L; Fahy J; Arimondo PB
J Med Chem; 2015 Mar; 58(6):2569-83. PubMed ID: 25406944
[TBL] [Abstract][Full Text] [Related]
11. Molecular modeling and virtual screening of DNA methyltransferase inhibitors.
Medina-Franco JL; Yoo J
Curr Pharm Des; 2013; 19(12):2138-47. PubMed ID: 23016844
[TBL] [Abstract][Full Text] [Related]
12. 7-Aminoalkoxy-Quinazolines from Epigenetic Focused Libraries Are Potent and Selective Inhibitors of DNA Methyltransferase 1.
Medina-Franco JL; López-López E; Martínez-Fernández LP
Molecules; 2022 Apr; 27(9):. PubMed ID: 35566242
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation and demethylation probed by small molecules.
Szyf M
Biochim Biophys Acta; 2010; 1799(10-12):750-9. PubMed ID: 20840878
[TBL] [Abstract][Full Text] [Related]
14. DNA Methyltransferase Inhibitors and their Therapeutic Potential.
Zhou Z; Li HQ; Liu F
Curr Top Med Chem; 2018; 18(28):2448-2457. PubMed ID: 30465505
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide identification, evolution of DNA methyltransferases and their expression during gonadal development in Nile tilapia.
Wang FL; Yan LX; Shi HJ; Liu XY; Zheng QY; Sun LN; Wang DS
Comp Biochem Physiol B Biochem Mol Biol; 2018 Dec; 226():73-84. PubMed ID: 30170023
[TBL] [Abstract][Full Text] [Related]
16. Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.
San José-Enériz E; Agirre X; Rabal O; Vilas-Zornoza A; Sanchez-Arias JA; Miranda E; Ugarte A; Roa S; Paiva B; Estella-Hermoso de Mendoza A; Alvarez RM; Casares N; Segura V; Martín-Subero JI; Ogi FX; Soule P; Santiveri CM; Campos-Olivas R; Castellano G; de Barrena MGF; Rodriguez-Madoz JR; García-Barchino MJ; Lasarte JJ; Avila MA; Martinez-Climent JA; Oyarzabal J; Prosper F
Nat Commun; 2017 May; 8():15424. PubMed ID: 28548080
[TBL] [Abstract][Full Text] [Related]
17. DNA methyltransferase inhibitors for cancer therapy.
Brueckner B; Kuck D; Lyko F
Cancer J; 2007; 13(1):17-22. PubMed ID: 17464242
[TBL] [Abstract][Full Text] [Related]
18. Role of protein-protein interactions in allosteric drug design for DNA methyltransferases.
Liang Z; Zhu Y; Liu X; Hu G
Adv Protein Chem Struct Biol; 2020; 121():49-84. PubMed ID: 32312426
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferases in hematologic malignancies.
Li KK; Luo LF; Shen Y; Xu J; Chen Z; Chen SJ
Semin Hematol; 2013 Jan; 50(1):48-60. PubMed ID: 23507483
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
Liu K; Liu Y; Lau JL; Min J
Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
